A study published in JAMA Internal Medicine has found that Januvia and Byetta, two popular GLP-1 therapies used for the treatment of diabetes, may greatly increase the risk of pancreatitis. The FDA flagged Byetta for pancreatitis in 2007 and … [Read more...]